North America dominated the global market in 2016, with the U.S. accounting for a major share of this regional market.

Geographically, the market is dominated by North America. Growth in the North American segment is primarily driven by the high incidence and prevalence of HIV/AIDS, increasing awareness about HIV/AIDS

The global process analytical technology (PAT) market is poised to reach USD 3.30 Billion by 2021 from USD 1.77 Billion in 2016, at a CAGR of 13.3% from 2016 to 2021.

North America accounted for the largest share of the global market. Growth in the North American market is primarily driven by the growing pharmaceutical industry, rising hi-tech industries

The global cholesterol testing services market is expected to reach USD 17.57 Billion by 2021 from USD 11.96 Billion in 2016, growing at a CAGR of 8% during the forecast period.

In this report, the ECG cable and ECG leadwires market is segmented on the basis of material, usability, leadwires by machine type, patient care setting and regions.

Geographically, the market is segmented into North America, Europe, Asia-Pacific, and RoW. Among the four geographic regions, North America is estimated to command the largest share of the market in 2016, followed by Europe and Asia-Pacific.

The global medical aesthetics market is estimated to grow at a CAGR of 10.8% during 2016 to 2021 and reach USD 13.29 Billion.

Emerging markets including China, India, South Africa, and the Middle East offer high growth potential for companies engaged in the development and distribution of prefilled syringes.

On the basis of products, the global market is further segmented into surgical wound care products, advanced wound care products, traditional wound care products, and therapy devices.

The global advanced wound care market is expected to reach USD 14.9 Billion by 2020 from USD 9.9 Billion in 2014, at a CAGR of 7.0% from 2015 to 2020

The global respiratory care devices market is segmented on the basis of products and end users. On the basis of products, the market is divided into therapeutic devices, monitoring devices, diagnostic devices, and consumables & accessories.

The report “Cosmetic Dentistry Market” analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and Rest of the World

Asia-Pacific represents an attractive destination for companies offering cold pain therapy products, mainly due to the high preference to topical analgesics for pain management and increasing arthritis incidence in the region.

Cold pain therapy is among the most commonly adopted methods for the temporary management of pain and inflammation, sprains, strains, bumps, bruises, and arthritis.

On the basis of end users, the market is classified into life science R&D and biopharmaceutical manufacturers. Biopharmaceutical manufacturers are the major end user of the market in 2016.

By application, the global genome editing market is categorized into cell line engineering, plant genetic engineering, animal genetic engineering, and other applications

The global blood gas analyzer market is expected to reach USD 636.0 Million by 2021 from USD 506.9 Million in 2016, growing at a CAGR of 4.6% from 2016 to 2021.

This report studies the global prepacked chromatography columns market during the forecast period (2014-2019). The market is estimated at $1.42 Billion in 2014, and is projected to reach $2.11 Billion by 2019, at a CAGR of 8.4% from 2014 to 2019.

In this report, the antibody production market is segmented on the basis of process and end users. On the basis of process, the market is categorized into upstream processing, downstream processing, and filtration.

Based on products, the ANA testing market is segmented into assay kits & reagents, systems, and software & services. The assay kits & reagents segment is expected to account for the largest share of the global ANA testing market in 2016.

The laboratory equipment services market is segmented based on service type, equipment type, service contracts, service provider, end user, and region.

The global regenerative medicines market is expected to reach USD 49.41 Billion by 2021 from USD 17.06 Billion in 2016, at a CAGR of 23.7%. The global market is broadly classified by product, application, therapy, and region.

Point-of-care blood gas analyzers offer significant growth opportunities owing to advantages such as low cost and short turnaround time

North America accounted for the largest market share of the global hyperspectral imaging Market, and it is expected to grow at a significant CAGR due to the growing demand for hyperspectral imaging techniques

North America is estimated to dominate the global blood gas analyzer market in 2016. The large share of this regional segment can primarily be attributed to the growing prevalence of lifestyle diseases, increasing number of product approvals

This report segments the genome editing market by application, technology, end user, and region. The application segments included in this report are cell line engineering, animal genetic engineering, plant genetic engineering, and other applications

Emerging markets, including India, China, Singapore, and Brazil, have become attractive destinations for companies engaged in the development and marketing of life science instrumentation products.

North America is estimated to dominate the global blood gas analyzer market in 2016. The large share of this regional segment can primarily be attributed to the growing prevalence of lifestyle diseases

The global regenerative medicines market is expected to reach USD 49.41 Billion by 2021 from USD 17.06 Billion in 2016, at a CAGR of 23.7%. The global market is broadly classified by product, application, therapy, and region.

On the basis of geography, this market is classified into four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, the global air quality monitoring market is estimated to be dominated by North America.

The liquid biopsy market is expected to reach USD 1.66 Billion by 2021 from USD 0.58 Billion in 2016, growing at a CAGR of 23.4% during the forecast period of 2016 to 2021.

On the other hand, the Asia-Pacific market is expected to witness the highest growth during the forecast period, owing to factors such as growing initiatives by market players and increasing patient population base in this region.

The report provides a granular understanding of the genome engineering market. This report segments the global genome editing market on the basis of applications, technologies, end users, and regions.

Pain management device are used to manage chronic and acute pain in patients suffering from various conditions, such as cancer, neurological disorders, and musculoskeletal disorders.

North America is expected to command the major market share in 2016; the large share of this regional segment can be attributed to the growing prevalence of lifestyle diseases, increasing number of product approvals

Wound care management is a growing field that has been witnessing a number of technological advancements lately. There are various products available in the market, which have made the treatment of wounds easier.

The hearing aids market is expected to reach USD 8,373.9 Million by 2020 from USD 6,183.3 Million in 2015, at a CAGR of 6.3%. This market is segmented based on products, type of hearing loss, end-user, and regions.

The global regenerative medicines market is expected to reach USD 49.41 Billion by 2021 from USD 17.06 Billion in 2016, at a CAGR of 23.7%. The global regenerative medicines market is broadly classified by product, application, therapy, and region.

The next generation sequencing market is expected to reach USD 10,371.1 Million by 2021 from USD 4,031.7 Million in 2016, at a CAGR of 20.8% between 2016 and 2021.

Despite the dominance of polymerase chain reaction (PCR) technology, INAAT is expected to seize a considerable market space in the global market since it enhances the quality of point-of-care testing using miniature DNA diagnostics.

According to the American Society for Testing and Materials (ASTM), ’additive manufacturing’ is the “process of joining materials to make objects from 3D model data, usually layer upon layer”.

The dental bone graft substitutes market is estimated to be valued at USD 416.3 Million in 2016, and is projected to reach USD 664.3 Million by 2021, at a CAGR of 9.8% from 2016 to 2021.

The global pharmaceutical excipients market is mainly segmented by product, by formulation, by functionality, and by region. The market is classified on the basis of product into inorganic chemicals, organic chemicals, and other chemicals.

The global bioabsorbable stents market is expected to reach USD 2.4 Billion by 2021 from USD 0.4 Billion by 2016, at a CAGR of 42.5% during the forecast period.

Pain management devices are used to manage chronic and acute pain in patients suffering from various conditions, such as cancer, neurological disorders, and musculoskeletal disorders.

Factors responsible for the growth of reagents segment are increasing number of research institutions, industry funding towards research and development, rising applications of functional imaging, growing adoption rate for clinical imaging.

The therapeutic drug Monitoring market is projected to reach USD 2.55 Billion by 2020 from USD 1.78 Billion in 2015, growing at a CAGR of 7.4% during the forecast period (2015–2020).

Diagnostic imaging market is highly competitive owing to the presence of a number of large and small firms. With improving public health for all population groups, the global diagnostic imaging market has been witnessing several product innovations.

Emerging markets including China, Korea, Taiwan, and India have become attractive destinations for outsourcing of clinical trials due to presence of large patient population and low operating cost in conducting clinical trials in these countries.